Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […]

Related Keywords

,Eton Pharmaceuticals Inc ,Goldman Sachs Group Inc ,Harrow Health ,Nasdaq ,Nuveen Asset Management ,Harrow Health Stock ,Barclays Plc ,Surface Ophthalmics Inc ,Pricet Rowe Associates Inc ,News Ratings For Harrow Health Daily ,Vanguard Group Inc ,Hedge Funds Weigh In On Harrow Health ,Opaleye Management Inc ,Harrow Health Inc ,Pharmaceuticals Inc ,Free Report ,Sachs Group ,Asset Management ,Opaleye Management ,Get Free Report ,Surface Ophthalmics ,Melt Pharmaceuticals ,Eton Pharmaceuticals ,Harrow Health Daily ,